Lukas Delasos

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “RET inhibition in novel patient-derived models of RET fusion- positive lung adenocarcinoma reveals a role for MYC upregulation”.

RET inhibition in novel patient-derived models of RET fusion- positive lung adenocarcinoma reveals a role for MYC upregulation

Disease Models & Mechanisms(2020)10.1242/dmm.047779

N/A

0DataRank · unranked

12 citations

Igor Odintsov, Roger S. Smith, Kota Ishizawa, Allan J. W. Liu, Lukas Delasos +17 more

The Anti-HER3 mAb Seribantumab Effectively Inhibits Growth of Patient-Derived and Isogenic Cell Line and Xenograft Models with Oncogenic NRG1 Fusions

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-3605

N/A

0DataRank · unranked

51 citations

Allan J.W. Lui, Whitney J. Sisso, Eric Gladstone, Zebing Liu, Lukas Delasos +10 more

Novel patient-derived models of desmoplastic small round cell tumor confirm a targetable dependency on ERBB signaling

Disease Models & Mechanisms(2021)10.1242/dmm.047621

N/A

0DataRank · unranked

33 citations

Igor Odintsov, Zebing Liu, Allan J.W. Lui, Takuo Hayashi, Morana Vojnic +22 more

Novel Preclinical Patient-Derived Lung Cancer Models Reveal Inhibition of HER3 and MTOR Signaling as Therapeutic Strategies for NRG1 Fusion-Positive Cancers

Journal of Thoracic Oncology(2021)10.1016/j.jtho.2021.03.013

N/A

0DataRank · unranked

32 citations

Marissa S. Mattar, Allan J.W. Lui, Michael Offin, Christopher Kurzatkowski, Lukas Delasos +9 more

Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC

Cancer Discovery(2023)10.1158/2159-8290.cd-22-1420

N/A

0DataRank · unranked

186 citations

Haniel A. Araújo, Giuseppe Lamberti, Alissa J. Cooper, Neal S. Akhave, Teng Zhou +61 more

Vepafestinib is a pharmacologically advanced RET-selective inhibitor with high CNS penetration and inhibitory activity against RET solvent front mutations

Nature Cancer(2023)10.1038/s43018-023-00630-y

N/A

0DataRank · unranked

38 citations

Igor Odintsov, Keiji Ishida, Allan J.W. Lui, Masanori Kato, Tatsuya Suzuki +28 more

1230 Novel imaging-based radiomics distinguishes radiation and immunotherapy induced pneumonitis in locally advanced NSCLC

Regular and Young Investigator Award Abstracts(2023)10.1136/jitc-2023-sitc2023.1230

N/A

0DataRank · unranked

0 citations

Mohammadhadi Khorrami, Vidya Sankar Viswanathan, Nathan A. Pennell, Anant Madabhushi, Pradnya D. Patil +1 more

Novel radiogenomics approach to predict and characterize pneumonitis in stage III NSCLC

npj Precision Oncology(2024)10.1038/s41698-024-00790-9

N/A

0DataRank · unranked

11 citations

Mohammadhadi Khorrami, Vidya Sankar Viswanathan, Khalid Jazieh, Yifu Ding, Pushkar Mutha +7 more

1222P Predicting pathological complete response to neoadjuvant chemoimmunotherapy in resected NSCLC with radiomic signatures

Annals of Oncology(2024)10.1016/j.annonc.2024.08.1281

N/A

0DataRank · unranked

1 citations

Pushkar Mutha, Lukas Delasos, Maedeh Zokaei Nikoo, Nathan A. Pennell, Anant Madabhushi +1 more

Computationally integrating radiology and pathology image features for predicting treatment benefit and outcome in lung cancer

npj Precision Oncology(2025)10.1038/s41698-025-00939-0

N/A

0DataRank · unranked

12 citations

Mohammadhadi Khorrami, Kaustav Bera, Pingfu Fu, Lukas Delasos, Amit Gupta +5 more